Porphyria Cutanea Tarda in a Patient with End-Stage Renal Disease: A Case of Successful Treatment with Deferoxamine and Ferric Carboxymaltose
Porphyria cutanea tarda (PCT) is a rare disease, with a strong association with hepatitis C virus. PCT is particularly problematic in end-stage renal disease patients as they have no renal excretion of porphyrins and these are poorly dialyzed. Also, conventional treatment of PCT is compromised in th...
Saved in:
Main Authors: | Natacha Rodrigues, Fernando Caeiro, Alice Santana, Teresa Mendes, Leonor Lopes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2017/4591871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Porphyria Cutanea Tarda with Constrictive Pericarditis: A Rare Association
by: Kaur Jasleen, et al.
Published: (2012-01-01) -
Porfiria cutánea tarda vs pseudoporfiria cutánea tarda en un paciente en hemodiálisis. Presentación de un caso
by: Eliseo Capote Leyva
Published: (2020-02-01) -
The experiences of ferric carboxymaltose desensitization and provocation
by: Fatma Dindar Çelik, MD, et al.
Published: (2025-02-01) -
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
by: Melvin H. Seid, et al.
Published: (2017-01-01) -
Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia
by: Aysun Seker, et al.
Published: (2025-01-01)